Product Name:Prl-8-53
Specification: 99%
Appearance: White Fine Powder
CAS Number: 51352-87-5
Molecular Formula: C18H22ClNO2
Test Method: HPLC
PRL-8-53 (chemical name Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate) is a synthetic nootropic compound discovered in 1972 and patented in 1975 by the late Dr. Nikolaus Hansl, a neuropharmacologist at Creighton University in Omaha, Nebraska. Preliminary animal tests indicated that the compound was both safe and significantly nootropic, boosting avoidance learning in rodents with no adverse effects. But the real interest in PRL-8-53 was sparked by a 1978 study on human volunteers, which showed that a single dose of the compound could improve word retention scores by more than 200%.
| Name | PRL-8-53 |
Synonyms: | PRL-8053;PRL-8-53;Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride;3-(2-Benzyl(methyl)aminoethyl)benzoic acid methyl ester hydrochloride;m-[2-(Benzylmethylamino)ethyl]benzoic acid methyl ester hydrochloride;Benzoic acid, 3-(2-(Methyl(phenylMethyl)aMino)ethyl)-, Methyl ester, hydrochloride |
CAS: | 51352-87-5 |
MF: | C18H22ClNO2 |
MW: | 319.82578 |
Nootropics also referred to as smart drugs, memory enhancers, neuro enhancers, cognitive enhancers, and intelligence enhancers, are drugs, supplements, nutraceuticals,and functional foods that purportedly improve mental functions such as cognition, memory, intelligence, motivation, attention, and concentration. Lyphar biotech produce kinds of Nootropics ,nootropics are thought to work by altering the availability of the brain's supply of neurochemicals (neurotransmitters, enzymes, andhormones) , by improving the brain's oxygen supply, or by stimulating nerve growth. |
|
PRL-8-53 is a nootropic research chemical derived from benzoic acid
and phenylmethylamine (Benzylamine) that has been shown to act as a hypermnesic drug in humans; it was first synthesized by medical chemistry professor Nikolaus Hansl atCreighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters.
PRL-8-53 is relatively non-toxic, with an oral LD50 in mice of 860 mg/kg,
giving the drug a high therapeutic index. Doses above 8 mg/kg have brief hypotensiveeffects in the canine.High doses depress motor activity in the rat and mouse, with the ED50 for a 50% reduction in motor activity of mice at 160 mg/kg.
1. Prl-8-53 can Enhance cognition and memory formation
2. Prl-8-53 can Anxiolytic properties
3. Prl-8-53 can Anti-depressive effect
4. Prl-8-53 can Treatment of Alzheimer's and Parkinson's disease
5. Prl-8-53 can Increase coordination
6. Prl-8-53 can Improves mood
7. Prl-8-53 can Help fight fatigue
8. Prl-8-53 can Prevent oxidation within the brain
9. Prl-8-53 can Treat alcohol related brain damage
10. Prl-8-53 can Prevent caffeine withdrawal symptoms
China
